Provectus Biopharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-21.9M | $-21.9M | — | — |
| FY2017 | $-10.3M | $-10.4M | $30.4K | — |
| FY2018 | $-5.2M | $-5.2M | — | $80.0K |
| FY2019 | $-6.2M | $-6.2M | — | $23.0K |
| FY2020 | $-4.1M | $-4.1M | — | $134.8K |
| FY2021 | $-1.0M | $-1.0M | — | $23.7K |
| FY2022 | $-3.0M | $-3.0M | — | $3.0K |
| FY2023 | $-2.6M | $-2.6M | — | $2.9K |
| FY2024 | $-3.3M | $-3.3M | — | $1.3M |
| FY2025 | $-3.3M | $-3.3M | — | $1.2M |